Table 2.

Cells tolerized to alloantigen inhibit cytokine production by naive alloreactive T cells but not naive DO11 CD4+cells exposed to optimal ovalbumin concentration

Culture dayGroupIL-2IFN-γIL-4IL-10IL-13
Naive anti-B6 419 34 11 0  
Naive + tolerized anti-B6 0  
DO11, OVA + BALB/c APCs 1703 1163 59 40 62  
DO11, OVA, tolerized CD4+ + BALB/c APCs 1732 1218 41 28 88  
Naive anti-B6 943 142 14 1  
Naive + tolerized anti-B6 0  
DO11, OVA + BALB/c APCs 1749 1112 122 2449 1033  
DO11, OVA, tolerized CD4+ + BALB/c APCs 1662 1506 65 2092 992 
Culture dayGroupIL-2IFN-γIL-4IL-10IL-13
Naive anti-B6 419 34 11 0  
Naive + tolerized anti-B6 0  
DO11, OVA + BALB/c APCs 1703 1163 59 40 62  
DO11, OVA, tolerized CD4+ + BALB/c APCs 1732 1218 41 28 88  
Naive anti-B6 943 142 14 1  
Naive + tolerized anti-B6 0  
DO11, OVA + BALB/c APCs 1749 1112 122 2449 1033  
DO11, OVA, tolerized CD4+ + BALB/c APCs 1662 1506 65 2092 992 

Primary lymphocyte reaction (MLR) cultures were established either with naive BALB/c CD4+ T cells and irradiated, T cell-depleted B6 splenic stimulators or with DO11 CD4+ T cells, ovalbumin peptide at 5.0 μg/mL, and irradiated BALB/c splenic antigen-presenting cells. BALB/c CD4+ cells that were tolerized to B6 alloantigen were added to some wells. Supernatants were harvested on days 3 and 5 of culture. Final concentration of naive BALB/c CD4+ cells was 0.5 × 106 cells per milliliter. Final concentration of DO11 CD4+ cells was 0.15 × 106 cells per milliliter. Tolerized cells were added at a ratio of 1 tolerized cell to 3 naive BALB/c CD4+ cells and 1 tolerized cell to 1 DO11 CD4+ cell. Values are in pg per milliliter.

IL indicates interleukin; IFN, interferon; OVA, ovalbumin; APCs, antigen-presenting cells.

Close Modal

or Create an Account

Close Modal
Close Modal